RLMD - Relmada Therapeutics files for mixed shelf offering

Relmada Therapeutics (NASDAQ:RLMD) has filed for a mixed shelf offering. The amount has yet to be determined. The filing does not necessarily indicate that a sale has begun, or will occur in the future. The company intends to use the proceeds for working capital and general corporate purposes. The offering can include common stock, preferred stock, depositary shares, subscription rights, purchase contracts, units, and warrants. In December 2021, Relmada (RLMD) had an underwritten public offering that had gross proceeds of ~$150M.

For further details see:

Relmada Therapeutics files for mixed shelf offering